Purpose Over the past 20 years results of clinical trials have provided information that has
revolutionized the approach to management of venous thromboembolic disease. New …

The process of tissue factor initiated blood coagulation is discussed. Reactions of the blood
coagulation cascade are propagated by complex enzymes containing a vitamin K …

We have investigated the influence of alterations in plasma coagulation factor levels
between 50% and 150% of their mean values for prothrombin, factor X, factor XI, factor IX …

More than a dozen primary hematologic disorders have been associated with ischemic
stroke. Inherited deficiencies of antithrombin III, protein C, and protein S have been linked …

Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels are
associated, respectively, with either increased risk or apparent protective effects for …

Thrombophilia is an inherited or acquired predisposition to thrombosis. This article reviews
the clinical manifestations of thrombophilia and addresses common questions on laboratory …

Background: Treatment of patients with deep vein thrombosis and an antithrombin or protein
C or S deficiency is based on case reports and personal experience. Objective: To …

The role of the hemostatic system in predisposing to or precipitating coronary heart disease
(CHD) represents an under-researched area. In the past decade developments in …

This study prospectively evaluates hypercoagulable states in patients under 51 years of age
undergoing lower extremity revascularization for ischemia and assesses early outcome after …

Objectives‐The aim of our study was to evaluate the prevalence of antithrombin, protein C
and protein S deficiencies in consecutive ischemic stroke patients under 45. Material and …